These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 24597512)
1. The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis. Chowdhury R; Ganeshan B; Irshad S; Lawler K; Eisenblätter M; Milewicz H; Rodriguez-Justo M; Miles K; Ellis P; Groves A; Punwani S; Ng T Br J Radiol; 2014 Jun; 87(1038):20140065. PubMed ID: 24597512 [TBL] [Abstract][Full Text] [Related]
2. The challenge of intratumour heterogeneity in precision medicine. Seoane J; De Mattos-Arruda L J Intern Med; 2014 Jul; 276(1):41-51. PubMed ID: 24661605 [TBL] [Abstract][Full Text] [Related]
3. Implications of intratumour heterogeneity for treatment stratification. Crockford A; Jamal-Hanjani M; Hicks J; Swanton C J Pathol; 2014 Jan; 232(2):264-73. PubMed ID: 24115146 [TBL] [Abstract][Full Text] [Related]
4. Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging. Sala E; Mema E; Himoto Y; Veeraraghavan H; Brenton JD; Snyder A; Weigelt B; Vargas HA Clin Radiol; 2017 Jan; 72(1):3-10. PubMed ID: 27742105 [TBL] [Abstract][Full Text] [Related]
5. Cancer Precision Medicine: Why More Is More and DNA Is Not Enough. Schütte M; Ogilvie LA; Rieke DT; Lange BMH; Yaspo ML; Lehrach H Public Health Genomics; 2017; 20(2):70-80. PubMed ID: 28595192 [TBL] [Abstract][Full Text] [Related]
6. From K-space to Nucleotide: Insights Into the Radiogenomics of Brain Tumors. Elshafeey N; Hassan I; Zinn PO; Colen RR Top Magn Reson Imaging; 2017 Feb; 26(1):33-41. PubMed ID: 28079715 [TBL] [Abstract][Full Text] [Related]
7. Genomic and phenotypic heterogeneity in prostate cancer. Haffner MC; Zwart W; Roudier MP; True LD; Nelson WG; Epstein JI; De Marzo AM; Nelson PS; Yegnasubramanian S Nat Rev Urol; 2021 Feb; 18(2):79-92. PubMed ID: 33328650 [TBL] [Abstract][Full Text] [Related]
8. Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications. Zito Marino F; Bianco R; Accardo M; Ronchi A; Cozzolino I; Morgillo F; Rossi G; Franco R Int J Med Sci; 2019; 16(7):981-989. PubMed ID: 31341411 [TBL] [Abstract][Full Text] [Related]
9. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine. Audenet F; Yates DR; Cancel-Tassin G; Cussenot O; Rouprêt M BJU Int; 2012 Jun; 109(12):1864-70. PubMed ID: 22035299 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of liver cancer and personalized therapy. Li L; Wang H Cancer Lett; 2016 Sep; 379(2):191-7. PubMed ID: 26213370 [TBL] [Abstract][Full Text] [Related]
12. Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers. El Hussein S; Shaw KRM; Vega F Mod Pathol; 2020 Dec; 33(12):2422-2436. PubMed ID: 32620919 [TBL] [Abstract][Full Text] [Related]
13. Precision therapy for lymphoma--current state and future directions. Intlekofer AM; Younes A Nat Rev Clin Oncol; 2014 Oct; 11(10):585-96. PubMed ID: 25135367 [TBL] [Abstract][Full Text] [Related]
14. Progress in the clinical detection of heterogeneity in breast cancer. Song JL; Chen C; Yuan JP; Sun SR Cancer Med; 2016 Dec; 5(12):3475-3488. PubMed ID: 27774765 [TBL] [Abstract][Full Text] [Related]
15. Is high-risk cutaneous squamous cell carcinoma of the head and neck a suitable candidate for current targeted therapies? Zilberg C; Lee MW; Kraitsek S; Ashford B; Ranson M; Shannon K; Iyer NG; Ch'ng S; Low TH; Palme C; Clark J; Gupta R; Yu B J Clin Pathol; 2020 Jan; 73(1):17-22. PubMed ID: 31300530 [TBL] [Abstract][Full Text] [Related]
19. New insights from the widening homogeneity perspective to target intratumor heterogeneity. Tong M; Deng Z; Zhang X; He B; Yang M; Cheng W; Liu Q Cancer Commun (Lond); 2018 May; 38(1):17. PubMed ID: 29764517 [TBL] [Abstract][Full Text] [Related]